Clinical Outcomes Solutions is pleased to announce that Jennifer Beaumont has joined the growing team as a Senior Director of Quantitative Sciences – Biostatistics. Jennifer has spent much of her career as a statistical analyst and has worked at the Center for Outcomes Research and Education and at Northwestern University where she was involved in development, validation, and application of …
FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic
The recent FDA guidance on conducting clinical trial during the COVID-19 pandemic mirrors our response policy to minimize study participant contact and engage in phone or video calls wherever possible. Great to see COS is ahead of the curve. Read full FDA guidance as PDF here
The COS team will be attending ISPOR Europe, 2019
The COS leadership team will be attending ISPOR Europe in Copenhagen in November as follows: Hudgens S, Pelletier C, Newton L, Howerter A, Gaines J, Keith S, Ung B, Udeze C, Evans C. Disease burden in patients with mild psoriasis: group concept mapping (PSS23). Presented at the International Society for Pharmacoeconomics and Outcomes Research Europe 2019; Wednesday 6 November, 09:30-14:00 …
COS will be attending ISOQOL
Sunday 20 October Tuesday 22 October 2:29 pm – 2:37 pm (B202.4) Research Designs for Optimizing Data Collected from Multiple Sources in Real-World Populations Stacie Hudgens, Clinical Outcomes Solutions, Tucson, AZ, United States
Tara Symonds CSO and Stacie Hudgens CEO present on establishing the reliability of the 5 Domain NPCSS ClinRO
The poster is being presented at ‘Society for the Study of Inborn Errors of Metabolism (SSIEM)’ Annual Symposium 2019; Rotterdam, Netherlands; 3 6 September 2019.
The COS team will be attending ISPOR US, 2019
The COS team will be presenting at ISPOR US in New Orleans in May as follows: Barsdorf A, Symonds T, Bush N. Introduction to Patient Reported Outcomes (short course).Course date: 18 May 2019; 08:00–12:00 Burbridge C, Kelly K, Garcia L, Dunaway Young S, Montes J, Johnson NB, Paradis A, Teynor M. Mapping a Qualitative Exploration of Meaningful Change in Later-onset …
COS announces oncology-focused research group
In 2018, COS celebrated its 5th anniversary, this year, we are thrilled to announce the launch of Oncology Outcomes: Strategic Advisory Partnership. This oncology-focused research partnership led by Stacie Hudgens is launched in collaboration with global thought-leader, Alicyn Campbell, will expand the resources and expertise available to our clients. Furthering allowing COS to be at the forefront of patient-related strategies …
Implementing patient-reported outcome measures in clinical practice
Article from Senior Director, Clinical Outcome Assessments, Louise Newton MSc. The use of patient-reported outcome (PRO) measures in clinical practice is increasing. Following the creation of a ‘User’s Guide to Implementing PRO Assessment in Clinical Practice’ by the International Society for Quality of Life Research (ISOQOL), volunteers from ISOQOL sought to create a Companion Guide to assist health care providers …
Recent presentations at ISPOR EU Barcelona from the COS team
The COS team will be presenting at ISPOR as follows: Crawford B, Kim HR, Newton L, Symonds T. Roadblocks and resolutions: development of PRO instruments for multinational trials (Workshop 1).Presentation date: 12 November 2018; 11:15–12:15 Hudgens S, Newton L, Eremenco S, Crescioni M, Symonds T, Griffiths P,Knight-West O, Reasner DS, Byrom B, O’Donohoe P, Vallow S. Comparability of a provisioned …
COS Senior Director, Louise Newton awarded JPRO Article of the Year
We are excited to announce that Louise Newton’s article, “A comparison of three methods to generate a conceptual understanding of a disease based on the patients’ perspective.” published in Journal of Patient-Reported Outcomes in 2017, has been awarded the ISOQOL Outstanding Article of the Year Award. The award recognizes and honors the single best article dedicated to health-related quality of …